| NCT Number | NCT07551713 |
| Lead Sponsor | Haisco Pharmaceutical Group Co., Ltd. |
| Conditions | Healthy |
| Enrollment | 40 participants |
| Start Date | 2020-06-11 |
| Primary Completion | 2020-07-10 (estimated) |
| Study Completion | 2020-09-28 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-27 |